To a very large extent the function of the alimentary system is to move things about. Food and secretions are moved in, chyme and chyle are moved along, faeces are moved out and, at the molecular level, nutrients are moved out of the gut lumen and into the blood. When the system is diseased or malfunctioning, these movements are often reduced and sometimes reversed. The ideal tool for following movement within the body is the radioactive tracer. It is surprising, therefore, that the use of radioactive tracers has not caught on more in the practice of gastroenterology, especially as radioisotope tests are largely noninvasive. But times are changing. Several new tests have been developed in recent years which allow gut function to be studied at various levels simply and safely. These tests allow us to watch the gut at work without interfering with it in any way. So, for the first time, we can establish the true range of normality as well as the patterns ofdisturbed function.
Several of these tests were discussed at the meeting of the Section of Measurement in Medicine on 30 September 1985 entitled 'New radioisotope tests in gastroenterology'. It was billed as an international meeting and, indeed, in the morning there were contributions from the USA, Italy and Germany. The morning was devoted to one test -the 75SeHCAT retention test for bile acid malabsorption.
75SeHCAT test The background to this particularly ingenious test was explained by Alan Hofmann of San Diego, the world's leading authority on bile acid physiology and a brilliant communicator. The clinician has two reasons for being interested in a test of bile acid absorption. First, since bile acids are reabsorbed chiefly in the terminal ileum, the 7'SeHCAT test provides for the first time a practical way ofdetecting dysfunction and disease of the terminal ileumthe part of the gut which is hardest to examine and yet is the commonest site of Crohn's disease. Second, there are patients with chronic diarrhoea of unknown cause who can be shown to have idiopathic bile acid malabsorption, the diarrhoea being caused by the purgative properties of dihydroxy bile acids spilling into the colon. It is important to make this diagnosis because the diarrhoea can be cured by oral administration of a bile-acid sequestering resin. One might ask whether bile-acid diarrhoea cannot be diagnosed more cheaply by a therapeutic trial of such a resin. The answer given to the meeting by Dr Malcolm Merrick of Edinburgh, who has more experience of the "SeHCAT test than anyone else, was that, in some patients, it can be difficult to find the right dose of cholestyramine and, unless one has the confidence of knowing that the treatment is appropriate, one might give up the trial too soon, without trying several doses.
What are the drawbacks of the "SeHCAT? The test takes a week. It is not cheap at £50 a dose and it is labour-intensive. It involves radiation, but we were assured by Dr Michael Short, physicist at University College Hospital, London, that even in a patient with cholestasis, the radiation dose to the main target organs, the liver and gallbladder, is of the same order as that resulting from standard X-ray and scintigraphic techniques. If retained 75SeHCAT is measured with an ordinary uncollimated gamma camera (which is likely to be the case unless one is lucky enough to have a shadow-shield monitor or, less likely, a whole-body counter) there can be problems from high background readings if, say, the next room contains a patient who has had 13 1 treatment. To get over this problem it may be necessary to work unsocial hours.
Ifthe "SeHCAT test is to give reliable information about bile acid metabolism, it is obviously essential that this artificial bile acid (taurohomocholic acid) should be handled by the body exactly like natural bile acids. The metabolism of "SeHCAT has been studied extensively by Dr T C Northfield's group at St George's Hospital and a member of this group, Dr R Jazrawi, reviewed the evidence. It transpires that 0141-0768/86/ 050306-03/$02.00/0 © 1986
The Royal Society of Medicine Journal of the Royal Society of Medicine Volume 79 May 1986 307 "SeHCAT differs from taurocholic acid in only one respect: it is deconjugated by intestinal bacteria much more slowly (2% versus 12% per day). Actually, this is an advantage as it means that 75SeHCAT (which, being very polar, is poorly absorbed by passive diffusion) depends for its reabsorption almost entirely on the active transport system for bile acids which is located only in the terminal ileum; hence, malabsorption of 75SeHCAT is synonymous with malfunction of the terminal ileum.
As a research tool "SeHCAT is elegant and powerful. It makes it possible to study the enterohepatic circulation of bile acids more easily and in greater detail than ever before.
To the clinician, the critical question is how useful is the 75SeHCAT test? To be useful it must not only be sensitive and specific, which it clearly is, but its results must be clinically relevant and must add to the doctor's understanding of his patient's problem. When ileal Crohn's disease causes persistent diarrhoea it is usually obvious on barium radiology. Radiation damage to the ileum is less easily proved radiologically and 75SeHCAT may be the only positive diagnostic test. But the patients in whom the test is most likely to be useful are those with chronic diarrhoea of unknown cause, who are usually labelled as irritable bowel syndrome or functional diarrhoea. Dr G Sciaretta from Bologna had collected 40 such patients and reported that no less than 19 turned out to have idiopathic bile acid malabsorption, of whom 17 were helped by cholestyramine. Some in the audience did not consider that they saw such patients frequently enough to justify setting up the test. Others wondered if positive responses occurring in a condition which responds to such diverse treatments as codeine phosphate and stress management could not be considered as false positives. Patients with the irritable bowel are a very heterogeneous group of people. In Merrick's experience, only 12% have substantial malabsorption of bile acids; another 18% have borderline malabsorption and 70% have normal "5SeHCAT retention. Doubtless the result can vary from time to time in patients with alternating diarrhoea and constipation. 7"SeHCAT should help us to understand this perplexing group of patients who occupy so much of gastroenterologists' time.
Constipation, or at least colonic stasis, interferes with the 75SeHCAT test, giving falsely high retention values. This can be overcome in two ways. One is to give a marker of colonic transit at the same time, such as 51CrC13, and this was well demonstrated by Dr R Ferraris of Turin and his colleagues at St George's. However, the use of a transit marker means that stools must be collected and counted, so the advantage of simplicity is lost. The other, simpler method is to measure gallbladder retention of "5SeHCAT instead of total abdominal retention. This avoids 'contamination' from radioactive stools held up in the colon and can be done satisfactorily with an uncollimated gamma camera. Admittedly, the test is not likely to be requested often in people with colonic stasis. But, as Dr Ferraris pointed out, the incidence of demonstrable bile acid malabsorption in Crohn's disease increases dramatically (from 30 to 70%, in his series) if you correct the "SeHCAT results for colonic retention. This is a test with great appeal for purists and intellectuals but perhaps less appeal for pragmatists. 51 CrEDTA test for intestinal permeability You will not find a section on 'The Leaky Intestine' in textbooks of medicine or gastroenterology. However, modern research is turning up more and more conditions in which the small bowel is more permeable than normal. The Northwick Park group working under Professor Timothy Peters has done more than any other to expose the commonness of leaky guts, using as a probe 51CrEDTA (ethylene diamine tetra-acetic acid), whose molecular weight is 346 daltons. Its great advantage is that any absorbed EDTA is quantitatively excreted in the urine; also it is cheap and easily measured. When a normal person swallows a dose of EDTA he excretes less than 2.5% of it in his urine over the next 24 hours. Patients with coeliac disease excrete 5-15% and raised urinary levels are also found with Crohn's disease of the small bowel.
Professor Peters advocated the 51CrEDTA test as a screening test for organic small bowel disease, and it undoubtedly fills the requirements of being quick, noninvasive and so sensitive that very few cases are missed. Like other screening tests it suffers from false positives. Alcohol, excess treatment with nonsteroidal anti-inflammatory drugs and, according to one member of the audience, food allergy, can all make the small intestine more permeable. But such cases are easily identified and the rest can be submitted to, say, jejunal biopsy or small bowel X-rays in high expectation of a diagnostic result.
"'Indium-labelled white cells and inflammatory bowel disease
This test has caused quite a stir in gastroenterological circles. It is elegant in conception, it is noninvasive to the patient and it gives the doctor precise and comprehensive information about inflammatory bowel diseasenot just whether or not it is there, but how extensive it is, how active it is (if faeces are collected and counted) and even whether or not it is complicated by abscess formation. Dr S H Saverymuttu at Hammersmith Hospital, London, has published more about this test than anyone else and he gave the meeting an illuminating account of its use.
Most impressive were the abdominal scans showing graphically that, for instance, ulcerative colitis extended to the hepatic flexure or that Crohn's disease involved two or three different areas of intestine. Injected, autologous white cells collect there because inflamed areas are where granulocytes congregate. Best results are obtained with labelled granulocytes rather than mixed leukocyte preparations, but these are more difficult to prepare.
In fact, the one drawback of the " 'indium-white cell test (apart from its cost, of about £50) is the time it takes to prepare and label the patient's white cells. Some centres have had so much difficulty they have given up. There is certainly scope for a simpler and cheaper test, at least for screening purposes. This is why there is interest in the test discussed next.
99mTc-porphyrins for assessing intestinal inflammation
Nobody knows quite why porphyrins collect in inflamed intestine but they do and, since they are cheap and easily labelled with the widely available technetium, they have the making of an ideal screening test for inflammatory bowel disease. But it is too early to say if the test has all the required properties.
Only Dr Ingvar Bjarnason of Northwick Park Hospital has much experience with it, using 99mTctetraphenyl porphyrine sulphonate (TPPS). He has obtained good correlations with the results of 111indium leukocyte scans in a small series of patients with Crohn's disease, but unreliable results in ulcerative colitis. Other problems awaiting solutions are the heterogeneity of the porphyrin preparation and the difficulty in preparing batches of it consistently.
Scintigraphic demonstration of reflux Surprisingly, work is only just starting on the use of radioisotopes to demonstrate gastro-oesophageal reflux, an exceedingly common condition. One reason may be the advent of 24-hour ambulatory pH monitoring which gives so much information and is probably the gold standard at present. Dr P Isaacs of Blackpool Victoria Hospital finds that when 99mTc-sulphur colloid is swallowed with a mouthful of water and the abdomen is compressed, reflux is detected with a sensitivity of only 73% compared with the pH probe. Doubtless the sensitivity of the test can be improved by modifying the technique, but a test like this will always suffer from one disadvantagethe most it can show is that reflux can occur in a particular, very artificial situation. It cannot tell whether reflux is occurring in a person's day-to-day life. Nevertheless, radionuclide imaging of the oesophagus is attractive because it is so simple. Also, it can be combined with measurement of oesophageal transit time, simply by following the passage of the radioactive bolus down the chest. Research in this field is active and we shall doubtless hear more soon.
The other kind of reflux which can cause dyspeptic symptoms is reflux of bile-rich duodenal fluid into the stomach. Interest in this is high because bile in the stomach leads to gastritis and, possibly, in the long term to gastric ulcer and cancer. Much has been learnt already by tests involving tubes in the stomach and duodenum, but such tests are uncomfortable and may even induce reflux. Only with the use of an isotopic gamma-emitter which is secreted into bile can one study bile reflux under physiological circumstances. Dr Keith Harding of Birmingham is one of many people studying bile reflux using 99mTclabelled diethyl HIDA (imino-diacetic acid) which, after intravenous injection, is rapidly excreted into bile. Gamma-camera imaging picks up reflux of as little as 1% of the injected dose into the stomach.
The test has imperfect reproducibility (75%), but Dr Harding has already made some interesting discoveries. Even normal subjects quite often have bile reflux after a liquid meal containing 20 g fat, and as many as 45% have it after cholecystokinin has been injected to make the gallbladder contract. Contrary to expectations, reflux was no more common in patients with gastric ulcer than in controls, nor was it especially common in gallstone patients who complained of flatulent dyspepsia. Curiously the presence of a radiologically non-functioning gallbladder was associated with a high incidence of reflux.
As research tools, radioisotopes undoubtedly have a great future in gastroenterology, and in the last talk of the day Dr Nick Read from Sheffield described how he has used 99mTc sulphur colloid to follow the progress of a normal meal through the gut and reported some of his many interesting findings on factors governing this progress.
To what extent the tests described will be used in the district general hospital in the future remains to be seen. Some senior gastroenterologists in the audience were sceptical, but my own bet is that some ofthem will find a place. Immunology and molecular biology of schistosomiasis Schistosomiasis remains a widespread disease, prevalent in many parts of the developing world. It is caused by infection with parasitic trematodes, schistosomes, which are transmitted by water snails which inhabit slow-moving rivers, lakes and pools. Infection is characteristically chronic. Enormous numbers of eggs are produced by the adult parasites in the mesenteric or pelvic veins. Some of the eggs lodge in the liver, intestine or urinary tract (depending on the parasite species involved), where they elicit granulomatous reactions and subsequent fibrosis.
Present control measures of schistosomiasis include drug treatment of infected individuals, improved sanitation, health education and the use of molluscicides. However, the widespread develop-ment of irrigation schemes, which encourage the propagation of the intermediate host, may lead to an increase in the number of infected individuals, the current estimate being about 200 million. Since a vaccine to protect against schistosomiasis has been considered as a possible way to control the disease, a considerable research effort has been undertaken in order to attempt to understand schistosome immunity in both man and experimental animals, and to investigate the possible stimulation of protective immunity using attenuated organisms or dead antigenic material in a vaccine. Several important advances in the immunology and molecular biology of schistosomiasis were presented at a meeting of the section of Clinical Immunology. & Allergy on 10 June 1985.
Protective immunity in man During the last decade doubts have been expressed as to whether protective immunity develops after infection in man. Although infection rates are 0141-0768/86/ 050308-04/$02.00/0 o 1986
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